Mechanical Left Ventricular Unloading in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation

• Published in: Journal of the American College of Cardiology Vol. 79; no. 13; pp. 1239 - 1250
• Main Authors: Grandin, E. Wilson, Nunez, Jose I., Willar, Brooks, Kennedy, Kevin, Rycus, Peter, Tonna, Joseph E., Kapur, Navin K., Shaefi, Shahzad, Garan, A. Reshad
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 05-04-2022
• Subjects: intra-aortic balloon pump; percutaneous ventricular assist device; survival; unloading; venoarterial extracorporeal membrane oxygenation; CHF; ECPR; intra-aortic balloon pump; percutaneous ventricular assist device; IABP; survival; MU; LV; VF; venoarterial extracorporeal membrane oxygenation; unloading; AMI; pVAD; VT; VA-ECMO
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2022.01.032

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases left ventricular (LV) afterload, potentially provoking LV distention and impairing recovery. LV mechanical unloading (MU) with intra-aortic balloon pump (IABP) or percutaneous ventricular assist device (pVAD) can prevent LV distension, potentially at the risk of more complications, and net clinical benefit remains uncertain.
This study aims to determine the association between MU and outcomes for patients undergoing VA-ECMO.
The authors queried the Extracorporeal Life Support Organization registry for adults receiving peripheral VA-ECMO from 2010 to 2019 and stratified them by MU with IABP or pVAD. The primary outcome was in-hospital mortality; secondary outcomes included on-support mortality and complications during VA-ECMO.
Among 12,734 VA-ECMO patients, 3,399 (26.7%) received MU: 2,782 (82.9%) IABP and 580 (17.1%) pVAD. MU patients were older (age 56.3 vs 52.7 years) and, before extracorporeal membrane oxygenation, more often required >2 vasopressors (41.7% vs 27.2%) and had respiratory (21.1% vs 15.9%), renal (24.6% vs 15.8%), and liver failure (4.4% vs 3.1%) (all P < 0.001). MU patients had lower in-hospital mortality (56.6% vs 59.3%, P = 0.006), which persisted in multivariable modeling (adjusted OR [aOR]: 0.84; 95% CI: 0.77-0.92; P < 0.001). MU was associated with more cannula site bleeding (aOR: 1.25; 95% CI: 1.11-1.40; P < 0.001) and hemolysis (aOR: 1.27; 95% CI: 1.03-1.57; P = 0.02). Compared to pVAD, MU patients with IABP had similar mortality (aOR: 0.80; 95% CI: 0.64-1.01; P = 0.06) and less medical bleeding (aOR: 0.45; 95% CI: 0.31-0.64; P < 0.001), cannula site bleeding (aOR: 0.72; 95% CI: 0.54-0.96; P = 0.03), and renal injury (aOR: 0.78; 95% CI: 0.62-0.98; P = 0.03).
Among adults receiving VA-ECMO, MU was associated with lower in-hospital mortality despite increased complications including hemolysis and cannulation site bleeding. Compared to pVAD, MU with IABP was associated with similar mortality and lower complication rates.
[Display omitted]